EARNEST Partners’s Myriad Genetics MYGN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-3,977,292
| Closed | -$35.3M | – | 294 |
|
2025
Q1 | $35.3M | Buy |
3,977,292
+5,694
| +0.1% | +$50.5K | 0.17% | 158 |
|
2024
Q4 | $54.5M | Buy |
3,971,598
+15,650
| +0.4% | +$215K | 0.24% | 140 |
|
2024
Q3 | $108M | Sell |
3,955,948
-116,070
| -3% | -$3.18M | 0.47% | 84 |
|
2024
Q2 | $99.6M | Buy |
4,072,018
+138,960
| +4% | +$3.4M | 0.47% | 87 |
|
2024
Q1 | $83.9M | Buy |
3,933,058
+19,145
| +0.5% | +$408K | 0.38% | 101 |
|
2023
Q4 | $74.9M | Buy |
3,913,913
+440,632
| +13% | +$8.43M | 0.37% | 109 |
|
2023
Q3 | $55.7M | Buy |
3,473,281
+219,503
| +7% | +$3.52M | 0.32% | 121 |
|
2023
Q2 | $75.4M | Buy |
3,253,778
+192,940
| +6% | +$4.47M | 0.42% | 103 |
|
2023
Q1 | $71.1M | Sell |
3,060,838
-243,618
| -7% | -$5.66M | 0.41% | 103 |
|
2022
Q4 | $47.9M | Sell |
3,304,456
-3,265,946
| -50% | -$47.4M | 0.29% | 124 |
|
2022
Q3 | $125M | Buy |
6,570,402
+108,264
| +2% | +$2.07M | 0.84% | 34 |
|
2022
Q2 | $117M | Buy |
6,462,138
+185,078
| +3% | +$3.36M | 0.78% | 42 |
|
2022
Q1 | $158M | Sell |
6,277,060
-39,305
| -0.6% | -$990K | 0.94% | 27 |
|
2021
Q4 | $174M | Buy |
6,316,365
+64,554
| +1% | +$1.78M | 1.01% | 28 |
|
2021
Q3 | $202M | Buy |
6,251,811
+58,332
| +0.9% | +$1.88M | 1.23% | 17 |
|
2021
Q2 | $189M | Sell |
6,193,479
-991,871
| -14% | -$30.3M | 1.11% | 24 |
|
2021
Q1 | $219M | Buy |
7,185,350
+453,921
| +7% | +$13.8M | 1.31% | 14 |
|
2020
Q4 | $133M | Buy |
6,731,429
+1,785,819
| +36% | +$35.3M | 0.92% | 35 |
|
2020
Q3 | $64.5M | Buy |
4,945,610
+184,528
| +4% | +$2.41M | 0.56% | 76 |
|
2020
Q2 | $54M | Buy |
4,761,082
+600,798
| +14% | +$6.81M | 0.51% | 86 |
|
2020
Q1 | $59.5M | Buy |
4,160,284
+561,534
| +16% | +$8.04M | 0.67% | 58 |
|
2019
Q4 | $98M | Buy |
3,598,750
+210,501
| +6% | +$5.73M | 0.77% | 51 |
|
2019
Q3 | $97M | Buy |
+3,388,249
| New | +$97M | 0.88% | 39 |
|